Starna Therapeutics is a biotechnology startup that is pioneering Extrahepatic RNA delivery. The company was founded in 2021 and is based in China. In its most recent funding round on 16 May 2022, Starna Therapeutics secured a significant CNY150.00M Series A investment from a consortium of prominent investors including Source Code Capital, Hony Capital, LYFE Capital, Primavera Capital, Hillhouse Investment, and Sherpa Venture Capital.
As a venture capital investor, the potential of Starna Therapeutics is underscored by its innovative approach to RNA delivery and its strategic positioning within the high-growth biotechnology sector. The company's strong backing from top-tier investors further validates its potential for long-term success and ability to create impact in the field of biotechnology. Starna Therapeutics' focus on Extrahepatic RNA delivery makes it a compelling player in a rapidly evolving industry. With a strong foundation and significant financial support, the company is poised to make substantial strides in advancing RNA-based therapeutics and could be a key player in shaping the future of biotechnology.
Starna Therapeutics
Pioneering Extrahepatic RNA delivery
Founded 2021
Suzhou, China
4 employees
Series A
Total: $160.00M
Biotechnology, Health and Wellness
Suzhou, China
4 employees
Series A
Total: $160.00M
Biotechnology, Health and Wellness
General Information
Get notified when Starna Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Starna Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
China Market
Biotechnology
About Starna Therapeutics
Taxonomy: RNA therapeutics, targeted therapies, tissue selective, biopharmaceuticals, patient needs
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 6 |
|
16 May 2022 |
| Angel Round | •••••• | 2 | •••• •••• | 01 Dec 2021 |
FAQ About Starna Therapeutics
Pioneering Extrahepatic RNA delivery
Starna Therapeutics was founded in 2021.
Starna Therapeutics is headquartered in Suzhou, China.
Starna Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Starna Therapeutics has approximately 4 employees.
Starna Therapeutics has completed 2 funding rounds, raising a total of $160.00M. The latest funding stage is Series A.
We're actively collecting intelligence on Starna Therapeutics.
Track Starna Therapeutics to get notifiedDon't just browse. Track.
Signal Tracker monitors Starna Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
